Here we found that, compared to normal samples, there was a significantly decreased expression of TPO receptor (MPL) in CML samples (Fig. 1A, B), particularly in CD34+ quiescent cells (Fig. 1B). The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.